Study to Evaluate the Incidence, Clinical Characteristics and Economic Burden of Dengue in Brazilian Children

NACompletedINTERVENTIONAL
Enrollment

2,117

Participants

Timeline

Start Date

September 6, 2011

Primary Completion Date

January 30, 2015

Study Completion Date

January 30, 2015

Conditions
Dengue
Interventions
OTHER

Data collection

Socio-demographic information, medical history, yellow fever vaccination history and dengue suspicion data collection.

PROCEDURE

Blood sample collection

A blood sample will be collected at each of the three scheduled study visits and any time during the study that dengue is suspected. Samples collected at scheduled visits will be tested for anti-dengue antibodies. Samples collected at visits for dengue suspicion will be tested for dengue diagnosis.

Trial Locations (1)

60430 160

GSK Investigational Site, Fortaleza

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01391819 - Study to Evaluate the Incidence, Clinical Characteristics and Economic Burden of Dengue in Brazilian Children | Biotech Hunter | Biotech Hunter